These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 16251219

  • 21. Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus.
    Li J, Xie H, Wen T, Liu H, Zhu W, Chen X.
    J Rheumatol; 2010 Apr; 37(4):766-75. PubMed ID: 20110525
    [Abstract] [Full Text] [Related]

  • 22. Mutual activation of CD4+ T cells and monocytes mediated by NKG2D-MIC interaction requires IFN-gamma production in systemic lupus erythematosus.
    Yang D, Wang H, Ni B, He Y, Li J, Tang Y, Fu X, Wang Q, Xu G, Li K, Yang Z, Wu Y.
    Mol Immunol; 2009 Apr; 46(7):1432-42. PubMed ID: 19200602
    [Abstract] [Full Text] [Related]

  • 23. Cytokine regulation of apoptosis and Bcl-2 expression in lymphocytes of patients with systemic lupus erythematosus.
    Graninger WB, Steiner CW, Graninger MT, Aringer M, Smolen JS.
    Cell Death Differ; 2000 Oct; 7(10):966-72. PubMed ID: 11279543
    [Abstract] [Full Text] [Related]

  • 24. Influence of functional interleukin 10/tumor necrosis factor-alpha polymorphisms on interferon-alpha, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment.
    López P, Gómez J, Prado C, Gutiérrez C, Suárez A.
    J Rheumatol; 2008 Aug; 35(8):1559-66. PubMed ID: 18597405
    [Abstract] [Full Text] [Related]

  • 25. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
    Tao J, Dong J, Li Y, Liu YQ, Yang J, Wu Y, Li L, Shen GX, Tan ZJ, Tu YT.
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
    [Abstract] [Full Text] [Related]

  • 26. Role of IL-10 in the abnormalities of early cell activation events of lymphocytes from patients with systemic lupus erythematosus.
    González-Amaro R, Portales-Pérez D, Baranda L, Abud-Mendoza C, Llorente L, Richaud-Patin Y, Alcocer-Varela J, Alarcón-Segovia D.
    J Autoimmun; 1998 Oct; 11(5):395-402. PubMed ID: 9802922
    [Abstract] [Full Text] [Related]

  • 27. Increased spontaneous but decreased mitogen-stimulated expression and excretion of interleukin 18 by mononuclear cells in patients with active systemic lupus erythematosus.
    Lee HT, Chen WS, Sun KH, Chou CT, Tsai CY.
    J Rheumatol; 2009 Sep; 36(9):1910-6. PubMed ID: 19605669
    [Abstract] [Full Text] [Related]

  • 28. Expression and function of IL-10R in mononuclear cells from patients with systemic lupus erythematosus.
    Valencia-Pacheco G, Layseca-Espinosa E, Niño-Moreno P, Portales-Pérez DP, Baranda L, Rosenstein Y, Abud-Mendoza C, González-Amaro R.
    Scand J Rheumatol; 2006 Sep; 35(5):368-78. PubMed ID: 17062437
    [Abstract] [Full Text] [Related]

  • 29. Analysis of expression and function of the inhibitory receptor ILT2 (CD85j/LILRB1/LIR-1) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus (SLE).
    Monsiváis-Urenda A, Niño-Moreno P, Abud-Mendoza C, Baranda L, Layseca-Espinosa E, López-Botet M, González-Amaro R.
    J Autoimmun; 2007 Sep; 29(2-3):97-105. PubMed ID: 17601702
    [Abstract] [Full Text] [Related]

  • 30. Anti-ribosomal P protein antibody in human systemic lupus erythematosus up-regulates the expression of proinflammatory cytokines by human peripheral blood monocytes.
    Nagai T, Arinuma Y, Yanagida T, Yamamoto K, Hirohata S.
    Arthritis Rheum; 2005 Mar; 52(3):847-55. PubMed ID: 15751081
    [Abstract] [Full Text] [Related]

  • 31. Proinflammatory interferon-gamma--inducing monokines (interleukin-12, interleukin-18, interleukin-15)--serum profile in patients with systemic lupus erythematosus.
    Robak E, Robak T, Wozniacka A, Zak-Prelich M, Sysa-Jedrzejowska A, Stepien H.
    Eur Cytokine Netw; 2002 Mar; 13(3):364-8. PubMed ID: 12231481
    [Abstract] [Full Text] [Related]

  • 32. Abnormal in vitro CXCR2 modulation and defective cationic ion transporter expression on polymorphonuclear neutrophils responsible for hyporesponsiveness to IL-8 stimulation in patients with active systemic lupus erythematosus.
    Hsieh SC, Wu TH, Tsai CY, Li KJ, Lu MC, Wu CH, Yu CL.
    Rheumatology (Oxford); 2008 Feb; 47(2):150-7. PubMed ID: 18208820
    [Abstract] [Full Text] [Related]

  • 33. Effects of calcitonin gene-related peptide on apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Liu C, Chen X, Jin Y, Qu R, Jiang PF, Wen GM, Tang ZH.
    Clin Exp Dermatol; 2007 Nov; 32(6):650-3. PubMed ID: 17725664
    [Abstract] [Full Text] [Related]

  • 34. Defective monocyte production of, and T lymphocyte response to, interleukin-1 in the peripheral blood of patients with systemic lupus erythematosus.
    Alcocer-Varela J, Laffon A, Alarcón-Segovia D.
    Clin Exp Immunol; 1984 Jan; 55(1):125-32. PubMed ID: 6229371
    [Abstract] [Full Text] [Related]

  • 35. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
    Yan B, Ye S, Chen G, Kuang M, Shen N, Chen S.
    Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
    [Abstract] [Full Text] [Related]

  • 36. Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha.
    Habib HM, Taher TE, Isenberg DA, Mageed RA.
    Scand J Rheumatol; 2009 Mar; 38(2):112-20. PubMed ID: 19110660
    [Abstract] [Full Text] [Related]

  • 37. Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus.
    Bertsias GK, Nakou M, Choulaki C, Raptopoulou A, Papadimitraki E, Goulielmos G, Kritikos H, Sidiropoulos P, Tzardi M, Kardassis D, Mamalaki C, Boumpas DT.
    Arthritis Rheum; 2009 Jan; 60(1):207-18. PubMed ID: 19116915
    [Abstract] [Full Text] [Related]

  • 38. Expression of interleukin-12 and its signaling molecules in peripheral blood mononuclear cells in systemic lupus erythematosus patients.
    Li Z, Li Y, Huang L, Xu H, Yu X, Ye R.
    Chin Med J (Engl); 2002 Jun; 115(6):846-50. PubMed ID: 12123550
    [Abstract] [Full Text] [Related]

  • 39. Increased population of CD4(+)CD25(high), regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients.
    Wang X, Zheng J, Liu J, Yao J, He Y, Li X, Yu J, Yang J, Liu Z, Huang S.
    Eur J Haematol; 2005 Dec; 75(6):468-76. PubMed ID: 16313258
    [Abstract] [Full Text] [Related]

  • 40. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE).
    Bonelli M, Savitskaya A, von Dalwigk K, Steiner CW, Aletaha D, Smolen JS, Scheinecker C.
    Int Immunol; 2008 Jul; 20(7):861-8. PubMed ID: 18469329
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.